- Home
- CRMD vs NVGS Comparison
CRMD vs NVGS Comparison
Compare CRMD & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- NVGS
- Stock Information
- Founded
- CRMD 2006
- NVGS 1997
- Country
- CRMD United States
- NVGS United Kingdom
- Employees
- CRMD N/A
- NVGS N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- NVGS Marine Transportation
- Sector
- CRMD Health Care
- NVGS Consumer Discretionary
- Exchange
- CRMD Nasdaq
- NVGS Nasdaq
- Market Cap
- CRMD 877.5M
- NVGS 994.3M
- IPO Year
- CRMD 2010
- NVGS N/A
- Fundamental
- Price
- CRMD $11.28
- NVGS $15.55
- Analyst Decision
- CRMD Strong Buy
- NVGS Strong Buy
- Analyst Count
- CRMD 7
- NVGS 3
- Target Price
- CRMD $17.33
- NVGS $22.00
- AVG Volume (30 Days)
- CRMD 2.2M
- NVGS 739.9K
- Earning Date
- CRMD 08-13-2025
- NVGS 08-13-2025
- Dividend Yield
- CRMD N/A
- NVGS 1.29%
- EPS Growth
- CRMD N/A
- NVGS 9.28
- EPS
- CRMD 0.28
- NVGS 1.27
- Revenue
- CRMD $82,553,827.00
- NVGS $583,931,000.00
- Revenue This Year
- CRMD $238.38
- NVGS $3.45
- Revenue Next Year
- CRMD $53.52
- NVGS N/A
- P/E Ratio
- CRMD $40.46
- NVGS $12.05
- Revenue Growth
- CRMD N/A
- NVGS 6.38
- 52 Week Low
- CRMD $3.61
- NVGS $10.55
- 52 Week High
- CRMD $17.43
- NVGS $17.53
- Technical
- Relative Strength Index (RSI)
- CRMD 39.54
- NVGS 64.85
- Support Level
- CRMD $11.13
- NVGS $14.92
- Resistance Level
- CRMD $11.86
- NVGS $15.67
- Average True Range (ATR)
- CRMD 0.65
- NVGS 0.44
- MACD
- CRMD -0.34
- NVGS 0.05
- Stochastic Oscillator
- CRMD 3.81
- NVGS 89.89
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.